Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Cells|October 14, 2020
Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by ChemotherapyDvir Shechter, Michal Harel, Abhishek Mukherjee, et al.
Cancers|June 2, 2021
Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung CancerMaryna Bondarenko, Marion Le Grand, Yuval Shaked, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus BevacizumabAngelica Calleri, Anna Bono, Vincenzo Bagnardi, et al.
Blood|February 11, 2005
The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cellsYuval Shaked, Dave Cervi, Manuela Neuman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancerSilvia Dellapasqua, Francesco Bertolini, Vincenzo Bagnardi, et al.
Molecular Cancer Therapeutics|April 19, 2015
Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous MetastasisTali Voloshin, Dror Alishekevitz, Limor Kaneti, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2022
Photopharmacological modulation of native CRAC channels using azoboronate photoswitchesRonald Udasin, Anwesha Sil, Elia Zomot, et al.
Cancer Research|April 6, 2006
Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxiaMarcela Franco, Shan Man, Limor Chen, et al.
Molecular Cancer Therapeutics|October 15, 2008
Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell linesGiulio Francia, Urban Emmenegger, Christina R Lee, et al.
Cancer Research|August 30, 2016
Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose ChemotherapyYuval Shaked, Elizabeth Pham, Santosh Hariharan, et al.
Pageof 14